v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2026
Apr. 30, 2025
Current assets:    
Cash and cash equivalents $ 8,719 $ 6,715
Restricted cash, short-term 154
Accounts receivable, net 587 1,191
Contract assets 590 1,088
Inventory 3,190 4,222
Other current assets 2,648 400
Total current assets 15,888 13,616
Property and equipment, net 10,255 3,444
Intangibles, net 3,357 3,490
Right-of-use assets, net 1,886 1,552
Restricted cash, long-term 154
Goodwill 8,537 8,537
Total assets 39,923 30,793
Current liabilities:    
Accounts payable 4,366 568
Earn out payable 150 300
Convertible notes payable (Note 13) 10,428
Accrued expenses 4,232 1,271
Contract liabilities, current 6,029
Right-of-use liabilities, current portion 1,202 1,150
Total current liabilities 26,407 3,289
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 837 649
Total liabilities 27,447 4,141
Commitments and contingencies (Note 15)  
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding
Common stock, $0.001 par value; authorized 400,000,000 and 300,000,000 shares, respectively, issued 231,145,998 and 172,050,563 shares, respectively, and outstanding 228,460,085 and 171,263,086 shares, respectively 231 172
Treasury stock, at cost; 2,685,913 and 787,477 shares, respectively (1,825) (1,018)
Additional paid-in capital 395,031 359,544
Accumulated deficit (380,961) (332,046)
Accumulated other comprehensive loss
Total shareholders’ equity 12,476 26,652
Total liabilities and shareholders’ equity $ 39,923 $ 30,793